A Second Study of Cytisinicline for Smoking Cessation in Adult Smokers
Public ClinicalTrials.gov record NCT05206370. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Second Multicenter, Double-blind, Randomized, Placebo-controlled Phase 3 Trial Evaluating the Efficacy and Safety of Cytisinicline in Adult Smokers
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This placebo-controlled Phase 3 study is being conducted at sites within the United States to evaluate 3 mg cytisinicline TID for treatment duration of 42 days/6 weeks and evaluate 3 mg cytisinicline TID for treatment duration of 84 days/12 weeks.
Study identification
- NCT ID
- NCT05206370
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 792 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 20, 2022 (Actual)
- Primary completion
- Mar 21, 2023 (Actual)
- Completion
- Mar 21, 2023 (Actual)
- Last update posted
- Jan 14, 2026
2022 – 2023
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Accel Research Sites - DeLand Clinical Research Unit | DeLand | Florida | 32720 | — |
| Alliance for Multispecialty Research, LLC | Fort Myers | Florida | 33912 | — |
| Jacksonville Center for Clinical Research | Jacksonville | Florida | 32216 | — |
| Affinity Health Corp | Oak Brook | Illinois | 60523 | — |
| MediSphere Medical Research Center, LLC | Evansville | Indiana | 47714 | — |
| Global Medical Institutes LLC; Princeton Medical Institute | Princeton | New Jersey | 08540 | — |
| Trial Management Associates, LLC | Wilmington | North Carolina | 28403 | — |
| Velocity Clinical Research, Inc. | Cleveland | Ohio | 44122 | — |
| Aventiv Research Inc | Columbus | Ohio | 43212 | — |
| Intend Research | Norman | Oklahoma | 73069 | — |
| Clinical Research Associates, Inc. | Nashville | Tennessee | 37203 | — |
| Health Research of Hampton Toads, Inc | Newport News | Virginia | 23606 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05206370, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 14, 2026 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05206370 live on ClinicalTrials.gov.